Helen Sabzevari

Insider Reports History

Location
Germantown, MD
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen Sabzevari:

Company Role Class Num Shares Value Price $ Report Date Ownership
PRECIGEN, INC. President and CEO, Director Common Stock 3,317,022 $4,809,681 $1.45 16 May 2025 Direct
PRECIGEN, INC. President and CEO, Director Restricted Stock Units 500,000 $1,877,698 $1.74 26 Jun 2025 Direct
PRECIGEN, INC. President and CEO, Director Option to Purchase Common Stock (Right to Buy) 1,000,000 23 May 2025 Direct
PRECIGEN, INC. President and CEO, Director Performance Stock Units 825,000 12 Sep 2025 Direct
Kinnate Biopharma Inc. Director Stock Option (right to buy) 0 03 Apr 2024 Direct

Insider Reports Filed by Helen Sabzevari

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PGEN PRECIGEN, INC. 12 Sep 2025 1 $0 4 President and CEO, Director 16 Sep 2025, 19:47
PGEN PRECIGEN, INC. 26 Jun 2025 1 $0 4 President and CEO, Director 27 Jun 2025, 16:08
PGEN PRECIGEN, INC. 23 May 2025 1 $0 4 President and CEO, Director 27 May 2025, 19:21
PGEN PRECIGEN, INC. 16 May 2025 3 -$755,775 4 President and CEO, Director 16 May 2025, 19:52
PGEN PRECIGEN, INC. 17 Apr 2025 1 $0 4 President and CEO, Director 18 Apr 2025, 16:58
PGEN PRECIGEN, INC. 29 Jan 2025 2 -$373,057 4 President and CEO, Director 03 Feb 2025, 20:07
PGEN PRECIGEN, INC. 31 May 2024 1 $0 4 President and CEO, Director 31 May 2024, 19:03
PGEN PRECIGEN, INC. 05 Apr 2024 4 -$574,500 4 President and CEO, Director 09 Apr 2024, 20:59
/report/000141588924010426-sabzevari-helen-2024-04-03 Kinnate Biopharma Inc. 03 Apr 2024 3 $0 4 Director 05 Apr 2024, 16:55
PGEN PRECIGEN, INC. 23 Aug 2023 3 -$117,763 4 President and CEO, Director 25 Aug 2023, 19:04
PGEN PRECIGEN, INC. 16 Aug 2023 3 -$92,719 4 President and CEO, Director 18 Aug 2023, 21:06
PGEN PRECIGEN, INC. 09 Aug 2023 3 -$59,668 4 President and CEO, Director 11 Aug 2023, 19:24
PGEN PRECIGEN, INC. 02 Aug 2023 3 -$58,157 4 President and CEO, Director 04 Aug 2023, 19:05
/report/000120919123036867-sabzevari-helen-2023-06-12 Kinnate Biopharma Inc. 12 Jun 2023 1 $0 4 Director 13 Jun 2023, 18:32
PGEN PRECIGEN, INC. 28 Apr 2023 1 $0 4 President and CEO, Director 02 May 2023, 17:53
PGEN PRECIGEN, INC. 24 Mar 2023 4 $0 4 President and CEO, Director 28 Mar 2023, 21:08
PGEN PRECIGEN, INC. 27 Jan 2023 1 +$40,000 4 President and CEO 30 Jan 2023, 18:23
PGEN PRECIGEN, INC. 04 Jan 2023 2 $0 4 President and CEO, Director 06 Jan 2023, 15:05
/report/000120919122037029-sabzevari-helen-2022-06-13 Kinnate Biopharma Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 17:01
PGEN PRECIGEN, INC. 12 May 2022 3 -$210,928 4 President and CEO, Director 16 May 2022, 18:57
PGEN PRECIGEN, INC. 18 Mar 2022 1 $0 4 President and CEO, Director 22 Mar 2022, 17:03
PGEN PRECIGEN, INC. 02 Feb 2022 1 $0 4 President and CEO, Director 04 Feb 2022, 16:06
PGEN PRECIGEN, INC. 04 Jan 2022 4 -$24,987 4 President and CEO, Director 06 Jan 2022, 16:08
PGEN PRECIGEN, INC. 02 Jan 2022 3 -$14,123 4 President and CEO, Director 04 Jan 2022, 16:07
PGEN PRECIGEN, INC. 17 Jul 2021 3 -$68,047 4 President and CEO, Director 20 Jul 2021, 18:11
/report/000120919121043448-sabzevari-helen-2021-06-24 Kinnate Biopharma Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 13:04
/report/000120919121043447-sabzevari-helen-2021-06-24 Kinnate Biopharma Inc. 24 Jun 2021 0 $0 3 Director 28 Jun 2021, 13:02
PGEN PRECIGEN, INC. 12 May 2021 3 -$303,571 4 President and CEO, Director 14 May 2021, 18:43